Meanwhile, tumors of the mesenchymal subtype contain cells with characteristics of cancer stem cells and are particularly sensitive to phosphatidylinositol 3-kinase-AKT-mechanistic target of rapamycin inhibitors (PI3K-AKT-mTOR). The gene discussed is AKT1; the disease is cancer.